glp 1 inflammatory bowel disease A surprising role for enteroendocrine cells and GLP-1 in regulating intestinal inflammation GLP-1R Agonists and Their Therapeutic

In the study, participants total mean weight loss was 26.6% over 84 weeks following a 12-week intensive lifestyle intervention and subsequent tirzepatide treatment

N-Acetyl-cysteine protection against lead-induced oxidative stress and genotoxicity in human liver carcinoma (HepG2) cells

[2] Michell L., et al

Similar content being viewed by others Introduction Type 2 diabetes mellitus (T2D), commonly linked with obesity, is a chronic metabolic disease characterized by insulin resistance and progressive failure of pancreatic -cells to meet the insulin secretory demand, resulting in poor glycaemic control associated with a multitude of co-morbidities, including metabolic dysfunction-associated steatotic liver disease (MASLD) 1,2 , diabetic kidney disease 3,4 , and cardiovascular dysfunction 5

INTERLEUKINS, MACROPHAGES, KERATINOCYTES, ENDOTHELIAL CELLS, LYMPHOCYTES, FIBROBLASTS, OSTEOBLASTS, BASOPHILS, MAST CELLS: Activates fibroblast differentiation